German Health Committee Questions Alzheimer's Medication Coverage
The Federal Joint Committee of doctors, health insurance funds, and clinics has decided that new Alzheimer's medications offer no proven additional benefit. This decision puts the coverage of treatment costs by health insurance funds in question. Agnes Flöhl expressed concern that the new therapy option could disappear before neurologists and neurologists can gain practical experience with it.
Topics
Developing
- 908d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 908d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 908d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 908d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
hr-iNFO
“Dennoch hat der gemeinsame Bundesausschuss von Ärzten Krankenkassen und Kliniken gerade entschieden die neuen Medikamente hätten keinen belegten Zusatz nutzen Eine Übernahme der Behandlungskosten durch die Krankenkassen ist damit infrage gestellt”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade